European Organization for Research and Treatment of Cancer
53 articles about European Organization for Research and Treatment of Cancer
-
Emergent BioSolutions Announces Presentation on Bispecific Protein Therapeutic at 24th Annual European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium
11/7/2012
-
Aileron Therapeutics Presents New Data on Stapled Peptide Oncology Program at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeut
11/7/2012
-
Caris Life Sciences Presents Study at American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference
11/17/2011
-
ZIOPHARM, Inc. Oncology Presents New Darinaparsin Preclinical Prostate and Pancreatic Cancer Data at American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer Meeting
11/16/2011
-
Curis, Inc. Presents Data on PI3K and HDAC Inhibitor CUDC-907 at the 2011 American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer Symposium
11/16/2011
-
AEterna Zentaris Presents Encouraging Preclinical Data for Disorazol Z (AEZS-137) at American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer Conference
11/16/2011
-
ZIOPHARM Oncology, Inc. Announces Promising Data from Phase 1b Study of Palifosfamide in Small Cell Lung and Other Cancers at American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer Mee
11/15/2011
-
Synta Pharmaceuticals Presents Results on Ganetespib and Hsp90 Inhibitor Class at the American Association for Cancer Research-European Organization for Research and Treatment of Cancer-National Cancer Institute Molecular Targets and Cancer Therapeutics C
11/15/2011
-
Myrexis, Inc. Presents at 2011 European Organization for Research and Treatment of Cancer/National Cancer Institute/American Association for Cancer Research Molecular Targets and Cancer Therapeutics Symposium
11/14/2011
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer Meeting
11/14/2011
-
Cerulean Pharma Inc. Presents Final Data from Phase 1/2a Clinical Study of CRLX101 at American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer
11/14/2011
-
Myrexis, Inc. to Present at 2011 European Organization for Research and Treatment of Cancer/National Cancer Institute/American Association for Cancer Research Molecular Targets and Cancer Therapeutics Symposium
11/4/2011
-
Selvita to Release the Most Recent Results from its Oncology Programs at the 2011 American Association for Cancer Research-European Organization for Research and Treatment of Cancer-National Cancer Institute Molecular Targets and Cancer Therapeutics Confe
10/24/2011
-
ZIOPHARM Oncology, Inc. Presents New Darinaparsin Preclinical Data at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Meeting
11/19/2010
-
ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Data for IMGN388 at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Ther
11/19/2010
-
AVEO Pharmaceuticals, Inc.'s Anti-RON Monoclonal Antibody Program Highlighted in Late-Breaker Plenary Presentation at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium
11/19/2010
-
Acceleron Pharma Announces Interim Findings from the ACE-041 Phase 1, First-in-Human Clinical Trial at 22nd European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecula
11/19/2010
-
Zalicus Inc. (Formerly Known as CombinatoRx, Incorporated) to Present Data on Oncology Programs at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets
11/18/2010
-
Curis, Inc. Presents CUDC-101 Phase I Clinical Data and CU-201 Preclinical Data at 22nd Curis, Inc.-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium
11/18/2010
-
Cerulean Pharma Inc. Presents Clinical and Pre-Clinical Nanopharmaceutical Data at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research
11/18/2010